| - GRCh38:
- Chr16:28486250-28486550
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Pathogenic (Aug 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28499002-28499003
- GRCh38:
- Chr16:28487681-28487682
| CLN3 | L119fs, L41fs, L65fs, L95fs | Neuronal ceroid lipofuscinosis 3 | Pathogenic (Feb 17, 2023) | criteria provided, single submitter |
| | CLN3 | | Neuronal ceroid lipofuscinosis 3 | Pathogenic (Sep 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28499930
- GRCh38:
- Chr16:28488609
| CLN3 | A19E, C38*, C92* | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Mar 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28497904
- GRCh38:
- Chr16:28486583
| CLN3 | Y122*, Y152*, Y176*, Y76*, Y98* | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28493855
- GRCh38:
- Chr16:28482534
| CLN3 | W183fs, W205fs, W229fs, W259fs, W283fs | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28493444
- GRCh38:
- Chr16:28482123
| CLN3 | W246*, W268*, W292*, W322*, W346* | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28493852
- GRCh38:
- Chr16:28482531
| CLN3 | Y184*, Y206*, Y230*, Y260*, Y284* | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28497735
- GRCh38:
- Chr16:28486414
| CLN3 | Q104*, Q126*, Q150*, Q180*, Q204* | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28498854-28498855
- GRCh38:
- Chr16:28487533-28487534
| CLN3 | V104fs, V128fs, V28fs, V50fs, V74fs | Neuronal ceroid lipofuscinosis 3 | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28497807
- GRCh38:
- Chr16:28486486
| CLN3 | V156M, V180M, V126M, V80M, V102M | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28497920
- GRCh38:
- Chr16:28486599
| CLN3 | S117F, S147F, S171F, S71F, S93F | Retinitis pigmentosa, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
| Conflicting interpretations of pathogenicity (May 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28500686
- GRCh38:
- Chr16:28489365
| CLN3 | N49K | Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis | Uncertain significance (Aug 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28499991
- GRCh38:
- Chr16:28488670
| CLN3 | | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 | Likely benign (Jun 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28499040
- GRCh38:
- Chr16:28487719
| CLN3 | L106H, L28H, L52H, L82H | Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Apr 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28494000
- GRCh38:
- Chr16:28482679
| CLN3 | | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 | Conflicting interpretations of pathogenicity (Sep 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28498858
- GRCh38:
- Chr16:28487537
| CLN3 | R103W, R127W, R27W, R49W, R73W | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28489128
- GRCh38:
- Chr16:28477807
| CLN3 | L276fs, L298fs, L322fs, L352fs, L376fs | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Jan 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr16:28493648
- GRCh38:
- Chr16:28482327
| CLN3 | W221*, W243*, W267*, W297*, W321* | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Mar 16, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28500658
- GRCh38:
- Chr16:28489337
| CLN3 | A5T, A59T | Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis, not provided
| Conflicting interpretations of pathogenicity (Nov 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28497668-28497972
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Pathogenic (Apr 16, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr16:28488779
- GRCh38:
- Chr16:28477458
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Mar 23, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28488726
- GRCh38:
- Chr16:28477405
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28497780
- GRCh38:
- Chr16:28486459
| CLN3 | G135W, G165W, G189W, G89W, G111W | Neuronal ceroid lipofuscinosis 3 | Uncertain significance (May 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28488650
- GRCh38:
- Chr16:28477329
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28503628
- GRCh38:
- Chr16:28492307
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28503543
- GRCh38:
- Chr16:28492222
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28503474
- GRCh38:
- Chr16:28492153
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28495358
- GRCh38:
- Chr16:28484037
| CLN3 | | Neuronal ceroid lipofuscinosis, not provided, Neuronal ceroid lipofuscinosis 3
| Conflicting interpretations of pathogenicity (Nov 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28493836
- GRCh38:
- Chr16:28482515
| CLN3 | V290I, V190I, V266I, V212I, V236I | Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Apr 28, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28500627
- GRCh38:
- Chr16:28489306
| CLN3 | S15W, S69W | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Feb 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28489171
- GRCh38:
- Chr16:28477850
| CLN3 | D284N, D362N, D262N, D308N, D338N | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Sep 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28489136
- GRCh38:
- Chr16:28477815
| CLN3 | | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 | Conflicting interpretations of pathogenicity (Aug 31, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28495366
- GRCh38:
- Chr16:28484045
| CLN3 | Q251*, Q151*, Q173*, Q227*, Q197* | Neuronal ceroid lipofuscinosis, Retinal dystrophy, Neuronal ceroid lipofuscinosis 3
| Pathogenic/Likely pathogenic (Nov 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28497968
- GRCh38:
- Chr16:28486647
| CLN3 | V101G, V55G, V131G, V77G, V155G | Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis, not provided
| Uncertain significance (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28495325
- GRCh38:
- Chr16:28484004
| CLN3 | | Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis | Pathogenic/Likely pathogenic (Dec 15, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28495335
- GRCh38:
- Chr16:28484014
| CLN3 | S161L, S207L, S237L, S183L, S261L | Inborn genetic diseases, Neuronal ceroid lipofuscinosis 3, not provided, Neuronal ceroid lipofuscinosis | Uncertain significance (Sep 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28497668-28497971
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Pathogenic (Jun 11, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28500715
- GRCh38:
- Chr16:28489394
| CLN3 | | Neuronal ceroid lipofuscinosis, not provided, Neuronal ceroid lipofuscinosis 3
| Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28497280-28498401
- GRCh38:
- Chr16:28485959-28487080
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Pathogenic (Jan 1, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28491981-28494795
- GRCh38:
- Chr16:28480660-28483474
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Pathogenic (Jan 8, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28488951
- GRCh38:
- Chr16:28477630
| CLN3 | S401R, S377R, S301R, S323R, S347R | Inborn genetic diseases, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
| Uncertain significance (Jul 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28488869
- GRCh38:
- Chr16:28477548
| CLN3 | P429S, P375S, P329S, P351S, P405S | not provided, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
| Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28488914
- GRCh38:
- Chr16:28477593
| CLN3 | I414V, I314V, I336V, I360V, I390V | Neuronal ceroid lipofuscinosis, not provided, Neuronal ceroid lipofuscinosis 3
| Uncertain significance (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28497701
- GRCh38:
- Chr16:28486380
| CLN3 | S215Y, S137Y, S115Y, S161Y, S191Y | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Sep 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28502884
- GRCh38:
- Chr16:28491563
| CLN3 | | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 | Uncertain significance (May 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28503034
- GRCh38:
- Chr16:28491713
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (May 29, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28493562-28493563
- GRCh38:
- Chr16:28482241-28482242
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Likely benign (Apr 6, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28499064
- GRCh38:
- Chr16:28487743
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Feb 6, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28502882
- GRCh38:
- Chr16:28491561
| CLN3 | | Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis | Conflicting interpretations of pathogenicity (Jun 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28495326
- GRCh38:
- Chr16:28484005
| CLN3 | | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 | Pathogenic/Likely pathogenic (Feb 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28499984
- GRCh38:
- Chr16:28488663
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Jun 20, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28502802
- GRCh38:
- Chr16:28491481
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (May 9, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28500637-28500638
- GRCh38:
- Chr16:28489316-28489317
| CLN3 | K66fs, K12fs | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Feb 7, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28489139
- GRCh38:
- Chr16:28477818
| CLN3 | Y372*, Y318*, Y272*, Y294*, Y348* | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Jan 31, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28503080
- GRCh38:
- Chr16:28491759
| CLN3 | M1V | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 | Pathogenic/Likely pathogenic (Aug 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28489187-28489188
- GRCh38:
- Chr16:28477866-28477867
| CLN3 | V303fs, V333fs, V257fs, V279fs, V357fs | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Jan 6, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28493521
- GRCh38:
- Chr16:28482200
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Dec 29, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28495369
- GRCh38:
- Chr16:28484048
| CLN3 | R250W, R172W, R150W, R226W, R196W | Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis | Uncertain significance (Aug 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28497730
- GRCh38:
- Chr16:28486409
| CLN3 | | not specified, Neuronal ceroid lipofuscinosis | Likely benign (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28499048
- GRCh38:
- Chr16:28487727
| CLN3 | | not specified, Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis
| Likely benign (Oct 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28493834
- GRCh38:
- Chr16:28482513
| CLN3 | | not specified, Neuronal ceroid lipofuscinosis | Likely benign (Feb 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28489168
- GRCh38:
- Chr16:28477847
| CLN3 | V363M, V263M, V309M, V339M, V285M | Inborn genetic diseases, not provided, Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis | Uncertain significance (Oct 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28495346
- GRCh38:
- Chr16:28484025
| CLN3 | E257D, E157D, E179D, E203D, E233D | not provided, Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis
| Uncertain significance (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28500681
- GRCh38:
- Chr16:28489360
| CLN3 | S51F | Neuronal ceroid lipofuscinosis 3, not provided, Neuronal ceroid lipofuscinosis
| Uncertain significance (Jul 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28497775-28497776
- GRCh38:
- Chr16:28486454-28486455
| CLN3 | A113fs, A91fs, A191fs, A137fs, A167fs | Neuronal ceroid lipofuscinosis, not provided, Neuronal ceroid lipofuscinosis 3
| Pathogenic (Sep 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28498790
- GRCh38:
- Chr16:28487469
| CLN3 | | not specified, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
| Conflicting interpretations of pathogenicity (Sep 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28500611
- GRCh38:
- Chr16:28489290
| CLN3 | M1T | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3, not provided
| Conflicting interpretations of pathogenicity (Aug 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28499967
- GRCh38:
- Chr16:28488646
| CLN3 | T80M, R7C, T26M | Neuronal ceroid lipofuscinosis 3, not provided, Neuronal ceroid lipofuscinosis
| Uncertain significance (Sep 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28497284-28498250
- GRCh38:
- Chr16:28485963-28486929
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Pathogenic (Jun 6, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28493851
- GRCh38:
- Chr16:28482530
| CLN3 | I285V, I207V, I261V, I185V, I231V | Retinal dystrophy, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
| Uncertain significance (Mar 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28499916
- GRCh38:
- Chr16:28488595
| CLN3 | T97M, T43M, R24W | Neuronal ceroid lipofuscinosis 3, Inborn genetic diseases, not specified, Neuronal ceroid lipofuscinosis | Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28499038
- GRCh38:
- Chr16:28487717
| CLN3 | P107S, P29S, P83S, P53S | Neuronal ceroid lipofuscinosis 3, not specified, Neuronal ceroid lipofuscinosis
| Uncertain significance (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28503049
- GRCh38:
- Chr16:28491728
| CLN3 | F11S | Neuronal ceroid lipofuscinosis 3, not provided, Neuronal ceroid lipofuscinosis
| Uncertain significance (Jul 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28489135
- GRCh38:
- Chr16:28477814
| CLN3 | V374I, V274I, V296I, V350I, V320I | Inborn genetic diseases, not provided, Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis | Uncertain significance (Jul 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28497974
- GRCh38:
- Chr16:28486653
| CLN3 | | Neuronal ceroid lipofuscinosis 3, not provided, Neuronal ceroid lipofuscinosis
| Conflicting interpretations of pathogenicity (Oct 26, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28493470
- GRCh38:
- Chr16:28482149
| CLN3 | R338C, R284C, R238C, R260C, R314C | Inborn genetic diseases, Neuronal ceroid lipofuscinosis, not provided, Neuronal ceroid lipofuscinosis 3 | Uncertain significance (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28488920
- GRCh38:
- Chr16:28477599
| CLN3 | T412A, T388A, T334A, T312A, T358A | not provided, Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis
| Uncertain significance (Mar 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28503081
- GRCh38:
- Chr16:28491760
| CLN3 | | Inborn genetic diseases, not provided, Neuronal ceroid lipofuscinosis 3
| Uncertain significance (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28495333
- GRCh38:
- Chr16:28484012
| CLN3 | K262*, K184*, K162*, K238*, K208* | not provided, Neuronal ceroid lipofuscinosis 3 | Pathogenic (Mar 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28493672
- GRCh38:
- Chr16:28482351
| CLN3 | L313P, L259P, L213P, L235P, L289P | Neuronal ceroid lipofuscinosis 3, not provided, Neuronal ceroid lipofuscinosis
| Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28497974
- GRCh38:
- Chr16:28486653
| CLN3 | | not provided, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
| Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28488941
- GRCh38:
- Chr16:28477620
| CLN3 | R405W, R351W, R305W, R327W, R381W | not provided, Retinitis pigmentosa, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3, Retinal dystrophy | Conflicting interpretations of pathogenicity (Jul 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28499968
- GRCh38:
- Chr16:28488647
| CLN3 | T80S, T26S, Q6H | Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis, not provided, Inborn genetic diseases | Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28493970
- GRCh38:
- Chr16:28482649
| CLN3 | R272W, R172W, R248W, R194W, R218W | not provided, Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3
| Uncertain significance (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28502800
- GRCh38:
- Chr16:28491479
| CLN3 | | Neuronal ceroid lipofuscinosis 3, not specified, Neuronal ceroid lipofuscinosis
| Conflicting interpretations of pathogenicity (May 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28493469
- GRCh38:
- Chr16:28482148
| CLN3 | R338H, R238H, R314H, R260H, R284H | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3, not specified
| Uncertain significance (Aug 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28493994
- GRCh38:
- Chr16:28482673
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Oct 12, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28497667
- GRCh38:
- Chr16:28486346
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Oct 19, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28499924-28499925
- GRCh38:
- Chr16:28488603-28488604
| CLN3 | S40fs, L21fs, S94fs | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Sep 6, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28503079
- GRCh38:
- Chr16:28491758
| CLN3 | M1T | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Aug 29, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28489196
- GRCh38:
- Chr16:28477875
| CLN3 | C353*, C253*, C299*, C329*, C275* | Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 | Pathogenic/Likely pathogenic (May 28, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28493520
- GRCh38:
- Chr16:28482199
| CLN3 | | Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis | Likely pathogenic (Jun 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28493796
- GRCh38:
- Chr16:28482475
| CLN3 | | not provided, Neuronal ceroid lipofuscinosis | Pathogenic/Likely pathogenic (Aug 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28503034
- GRCh38:
- Chr16:28491713
| CLN3 | | Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis | Likely pathogenic (May 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28495433-28495434
- GRCh38:
- Chr16:28484112-28484113
| CLN3 | L152fs, L206fs, L230fs, L176fs, L130fs | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Dec 21, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28493647
- GRCh38:
- Chr16:28482326
| CLN3 | | Neuronal ceroid lipofuscinosis 3 | Likely pathogenic (Nov 25, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28503528
- GRCh38:
- Chr16:28492207
| CLN3 | | Neuronal ceroid lipofuscinosis 3, Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive, not provided
| Conflicting interpretations of pathogenicity (Jul 7, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28503482
- GRCh38:
- Chr16:28492161
| CLN3 | | Neuronal ceroid lipofuscinosis 3, Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28503393
- GRCh38:
- Chr16:28492072
| CLN3 | | Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive, not provided, Neuronal ceroid lipofuscinosis 3
| Conflicting interpretations of pathogenicity (Jun 29, 2018) | criteria provided, conflicting interpretations |